Thyrocare Technologies Ltd

NSE: THYROCARE · BSE: 539871 · Healthcare · 55 announcements

Share price: ₹488.95
Market cap: ₹7,792 Cr
Revenue (annual): ₹829.0 Cr
Net profit (annual): ₹163.0 Cr
P/E (TTM): 54.0×Sector 54.5×
Promoter holding: 51.02%-9.90% QoQ
FII holding: 9.37%Current quarter

Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.

Announcement type

All Other Announcement 2 Earnings Call 2 Results Update 1 Merger & Restructuring 1 Management Change 1 Financial Results 1 Employee Stock Options 1 Board Meeting Date 1 Annual General Meeting 1

Time

All time Last 1 week Last 1 month Last 2 months Last 3 months Last 6 months Last 1 year

1 announcement with these filters

30 Oct 2026 17:28 IST BSE

Merger & Restructuring

Thyrocare Technologies Merger & Restructuring Worth ₹141.4 Cr

Thyrocare agreed to sell its entire stake in subsidiary Nueclear Healthcare to Trovera. The consideration is about Rs 141.40 Crore, including preference shares and cash.

Value: ₹141.4 Cr

Open announcement → Read the filing ↗